DOMESCO Medical Import Export JSC
Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical products, herbal-origin medicines, functional foods, purified drinking water, and herbal-based beverages in Vietnam. The company engages in the import and export of medicines, pharmaceutical raw materials, food and functional food ingredients, me… Read more
DOMESCO Medical Import Export JSC - Asset Resilience Ratio
DOMESCO Medical Import Export JSC (DMC) has an Asset Resilience Ratio of 25.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how DOMESCO Medical Import Export JSC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down DOMESCO Medical Import Export JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 0% |
| Short-term Investments | ₫491.00 Billion | 25.81% |
| Total Liquid Assets | ₫491.00 Billion | 25.81% |
Asset Resilience Insights
- Very High Liquidity: DOMESCO Medical Import Export JSC maintains exceptional liquid asset reserves at 25.81% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
DOMESCO Medical Import Export JSC Industry Peers by Asset Resilience Ratio
Compare DOMESCO Medical Import Export JSC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for DOMESCO Medical Import Export JSC (2019–2025)
The table below shows the annual Asset Resilience Ratio data for DOMESCO Medical Import Export JSC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.81% | ₫491.00 Billion | ₫1.90 Trillion | +10.92pp |
| 2024-12-31 | 14.89% | ₫274.00 Billion | ₫1.84 Trillion | -10.80pp |
| 2023-12-31 | 25.69% | ₫475.00 Billion | ₫1.85 Trillion | +3.65pp |
| 2022-12-31 | 22.04% | ₫405.00 Billion | ₫1.84 Trillion | +8.16pp |
| 2021-12-31 | 13.87% | ₫225.00 Billion | ₫1.62 Trillion | +5.33pp |
| 2020-12-31 | 8.54% | ₫125.00 Billion | ₫1.46 Trillion | -8.42pp |
| 2019-12-31 | 16.96% | ₫260.00 Billion | ₫1.53 Trillion | -- |